Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: Current status

Sam B. Bhayani; Mohamad E. Allaf; Louis R. Kavoussi

doi:10.1016/j.urolonc.2004.01.006

Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: Current status

Sam B. Bhayani
, Mohamad E. Allaf
, Louis R. Kavoussi

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options.

Original language	English
Pages (from-to)	145-148
Number of pages	4
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	22
Issue number	2
DOIs	https://doi.org/10.1016/j.urolonc.2004.01.006
State	Published - Mar 1 2004

Keywords

Germ cell tumor
Lymphadenectomy
Retroperitoneal lymph node dissection
Testis cancer

Access to Document

10.1016/j.urolonc.2004.01.006

Cite this

@article{fe49c0d26f474f5896c7dc846e58fd89,

title = "Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: Current status",

abstract = "The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options.",

keywords = "Germ cell tumor, Lymphadenectomy, Retroperitoneal lymph node dissection, Testis cancer",

author = "Bhayani, \{Sam B.\} and Allaf, \{Mohamad E.\} and Kavoussi, \{Louis R.\}",

year = "2004",

month = mar,

day = "1",

doi = "10.1016/j.urolonc.2004.01.006",

language = "English",

volume = "22",

pages = "145--148",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

number = "2",

}

TY - JOUR

T1 - Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer

T2 - Current status

AU - Bhayani, Sam B.

AU - Allaf, Mohamad E.

AU - Kavoussi, Louis R.

PY - 2004/3/1

Y1 - 2004/3/1

N2 - The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options.

AB - The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options.

KW - Germ cell tumor

KW - Lymphadenectomy

KW - Retroperitoneal lymph node dissection

KW - Testis cancer

UR - https://www.scopus.com/pages/publications/1842685278

U2 - 10.1016/j.urolonc.2004.01.006

DO - 10.1016/j.urolonc.2004.01.006

M3 - Article

C2 - 15082014

AN - SCOPUS:1842685278

SN - 1078-1439

VL - 22

SP - 145

EP - 148

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 2

ER -

Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: Current status

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this